Sara M. Alexanian, MD

Clinical Associate Professor, Medicine

Sara Alexanian
617.638.8545
720 Harrison Avenue (DOB-Doctors Office Building)

Biography

After graduating from Kalamazoo College with a double major in Biology and French Language and Literature, Dr. Sara Alexanian completed her medical degree at Dartmouth School of Medicine. Following an Internal Medicine Residency at Mount Auburn Hospital in Cambridge, MA, she completed her Endocrinology Fellowship training at Boston Medical Center. She then joined the faculty and is the Director of the Inpatient Diabetes Program at Boston Medical Center as well as the quality improvement director for her section. She specializes in the inpatient management of diabetes and has an interest in fellow and resident training, and is an active presenter for both trainees and faculty. Her academic interests include quality improvement, in particular as it relates to inpatient diabetes care.

Education

  • Dartmouth Medical School, MD
  • Kalamazoo College, BA

Publications

  • Published on 6/26/2021

    Charoenngam N, Alexanian SM, Apovian CM, Holick MF. Association between Hyperglycemia at Hospital Presentation and Hospital Outcomes in COVID-19 Patients with and without Type 2 Diabetes: A Retrospective Cohort Study of Hospitalized Inner-City COVID-19 Patients. Nutrients. 2021 Jun 26; 13(7). PMID: 34206813.

    Read at: PubMed
  • Published on 2/5/2021

    Bosch NA, Fantasia KL, Modzelewski KL, Alexanian SM, Walkey AJ. Guideline-Concordant Insulin Infusion Initiation Among Critically Ill Patients With Sepsis. Endocr Pract. 2021 Jun; 27(6):552-560. PMID: 33549815.

    Read at: PubMed
  • Published on 2/1/2021

    Bosch NA, Fantasia KL, Modzelewski KL, Alexanian SM, Walkey AJ. Racial Disparities in Guideline-Concordant Insulin Infusions during Critical Illness. Ann Am Thorac Soc. 2021 02; 18(2):368-371. PMID: 33001705.

    Read at: PubMed
  • Published on 1/11/2021

    Wirunsawanya K, Chittimoju S, Fantasia KL, Modzelewski KL, Steenkamp D, Alexanian SM. Insulin Requirements in Patients With Type 2 Diabetes Undergoing Bariatric Surgery in the Inpatient Setting and Upon Discharge: A Single-Center Retrospective Analysis of Insulin Management Strategies. Endocr Pract. 2021 Jun; 27(6):538-544. PMID: 34016530.

    Read at: PubMed
  • Published on 6/16/2020

    Pinardo H, Rubin SJ, Hashemi S, DePietro J, Pearce EN, Ananthakrishnan S, Alexanian SM, Steenkamp DW, Noordzij JP. The use of vitamin D in preventing post-thyroidectomy hypocalcemia: An endocrinologist survey study. Clin Endocrinol (Oxf). 2020 11; 93(5):598-604. PMID: 32469425.

    Read at: PubMed
  • Published on 3/30/2020

    Talutis SD, Lee SY, Cheng D, Rosenkranz P, Alexanian SM, McAneny D. The impact of preoperative carbohydrate loading on patients with type II diabetes in an enhanced recovery after surgery protocol. Am J Surg. 2020 10; 220(4):999-1003. PMID: 32252984.

    Read at: PubMed
  • Published on 8/16/2019

    Goundan PN, Willard DL, Sahin-Efe A, Fan SL, Alexanian SM. Comparison of bicarbonate values from venous blood gas and chemistry panels measured at the time of diagnosis and resolution of diabetes ketoacidosis. J Clin Transl Endocrinol. 2019 Dec; 18:100205. PMID: 31508318.

    Read at: PubMed
  • Published on 12/17/2018

    Vellanki P, Rasouli N, Baldwin D, Alexanian S, Anzola I, Urrutia M, Cardona S, Peng L, Pasquel FJ, Umpierrez GE. Glycaemic efficacy and safety of linagliptin compared to a basal-bolus insulin regimen in patients with type 2 diabetes undergoing non-cardiac surgery: A multicentre randomized clinical trial. Diabetes Obes Metab. 2019 04; 21(4):837-843. PMID: 30456796.

    Read at: PubMed
  • Published on 10/5/2018

    Blair RA, Palermo NE, Modzelewski KL, Alexanian SM, Baker WE, Simonson DC, McDonnell ME. REDUCED IMPACT OF DIABETES CLINIC REFERRAL ON HIGH-FREQUENCY EMERGENCY DEPARTMENT USERS. Endocr Pract. 2018 Dec; 24(12):1043-1050. PMID: 30289310.

    Read at: PubMed
  • Published on 6/1/2017

    Modzelewski KL, Rybin DV, Weinberg JM, Alexanian SM, McDonnell ME, Steenkamp DW. Active cocaine use does not increase the likelihood of hyperglycemic crisis. J Clin Transl Endocrinol. 2017 Sep; 9:1-7. PMID: 29067261.

    Read at: PubMed

View 21 more publications: View full profile at BUMC

View all profiles